 Bronchoalveolar Lavage Fluid
"Bronchoalveolar Lavage Fluid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.
| Descriptor ID |
D001992
|
| MeSH Number(s) |
E05.927.100.500
|
| Concept/Terms |
Bronchoalveolar Lavage Fluid- Bronchoalveolar Lavage Fluid
- Bronchoalveolar Lavage Fluids
- Lavage Fluid, Bronchoalveolar
- Lavage Fluids, Bronchoalveolar
- Bronchial Alveolar Lavage Fluid
- Pulmonary Lavage Fluid
- Lavage Fluid, Pulmonary
- Lavage Fluids, Pulmonary
- Pulmonary Lavage Fluids
- Lavage Fluid, Bronchial
- Lavage Fluid, Lung
- Lung Lavage Fluid
- Lavage Fluids, Lung
- Lung Lavage Fluids
- Alveolar Lavage Fluid
- Alveolar Lavage Fluids
- Lavage Fluid, Alveolar
- Lavage Fluids, Alveolar
- Bronchial Lavage Fluid
- Bronchial Lavage Fluids
- Lavage Fluids, Bronchial
|
Below are MeSH descriptors whose meaning is more general than "Bronchoalveolar Lavage Fluid".
Below are MeSH descriptors whose meaning is more specific than "Bronchoalveolar Lavage Fluid".
This graph shows the total number of publications written about "Bronchoalveolar Lavage Fluid" by people in this website by year, and whether "Bronchoalveolar Lavage Fluid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2004 | 0 | 3 | 3 | | 2005 | 0 | 2 | 2 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bronchoalveolar Lavage Fluid" by people in Profiles.
-
Jorth P, Ehsan Z, Rezayat A, Caldwell E, Pope C, Brewington JJ, Goss CH, Benscoter D, Clancy JP, Singh PK. Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis. Cell Rep. 2019 04 23; 27(4):1190-1204.e3.
-
Kavookjian H, Jones JW, Shah S, Escobar H, Swanson D, Nicklaus P. Endobronchial Non-Tuberculosis Mycobacterium Infection Presenting in a Healthy Child. Ann Otol Rhinol Laryngol. 2018 Oct; 127(10):726-730.
-
Bates JT, Pickens JA, Schuster JE, Johnson M, Tollefson SJ, Williams JV, Davis NL, Johnston RE, Schultz-Darken N, Slaughter JC, Smith-House F, Crowe JE. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine. 2016 Feb 10; 34(7):950-6.
-
Mej?as A, Ch?vez-Bueno S, Raynor MB, Connolly J, Kiener PA, Jafri HS, Ramilo O. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model. Virol J. 2007 Oct 25; 4:109.
-
Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun. 2007 Jan; 75(1):236-42.
-
Fonseca-Aten M, Okada PJ, Bowlware KL, Chavez-Bueno S, Mejias A, Rios AM, Katz K, Olsen K, Ng S, Jafri HS, McCracken GH, Ramilo O, Hardy RD. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2006 Oct; 97(4):457-63.
-
Ehlert CA, Truog WE, Thibeault DW, Garg U, Norberg M, Rezaiekhaligh M, Mabry S, Ekekezie II. Hyperoxia and tidal volume: Independent and combined effects on neonatal pulmonary inflammation. Biol Neonate. 2006; 90(2):89-97.
-
Fonseca-Aten M, Salvatore CM, Mej?as A, R?os AM, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Hardy RD. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Oct; 49(10):4128-36.
-
Ch?vez-Bueno S, Mej?as A, G?mez AM, Olsen KD, R?os AM, Fonseca-Aten M, Ramilo O, Jafri HS. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J. 2005 May 25; 2:46.
-
Merrill JD, Ballard RA, Cnaan A, Hibbs AM, Godinez RI, Godinez MH, Truog WE, Ballard PL. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res. 2004 Dec; 56(6):918-26.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|